- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05396482
Assesment of Hearing in Patients With Vestibular Migra
May 25, 2022 updated by: Rahma Alaa Kamel
Assesment of Hearing in Patients With Vestibular Migraine
Evaluation of hearing in patients with vestibular migraine
Study Overview
Status
Enrolling by invitation
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
25
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Assiut, Egypt, 088
- Assiut University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients with vestibular migraine
Description
Inclusion Criteria:
- vertigo
Exclusion Criteria:
- hypertension
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Patients with vestibular migraine and their relative
|
Pure tone audiometer
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pathology
Time Frame: 2 years
|
For vestibular migraine
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2020
Primary Completion (Anticipated)
May 1, 2023
Study Completion (Anticipated)
May 18, 2023
Study Registration Dates
First Submitted
May 25, 2022
First Submitted That Met QC Criteria
May 25, 2022
First Posted (Actual)
May 31, 2022
Study Record Updates
Last Update Posted (Actual)
May 31, 2022
Last Update Submitted That Met QC Criteria
May 25, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Rahma93
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vestibular Migraine
-
Ege UniversityCompletedVestibular Migraine | Vestibular Disorder | Migraine Variant
-
Otolith LabsMCRAEnrolling by invitationVestibular Migraine | Migraine Associated VertigoUnited States
-
Massachusetts Eye and Ear InfirmaryWithdrawnMigraine Disorders | Vestibular Diseases | Vestibular MigraineUnited States
-
Robert W. BalohCompletedVestibular Migraine | Migrainous VertigoUnited States
-
University of MalayaNot yet recruitingVestibular MigraineMalaysia
-
Pamukkale UniversityRecruiting
-
Assiut UniversityNot yet recruiting
-
First Affiliated Hospital of Jiaxing UniversityNot yet recruiting
-
University of California, San FranciscoEli Lilly and CompanyRecruiting
-
Mayo ClinicCompletedVestibular Migraine | Chronic Subjective DizzinessUnited States
Clinical Trials on Pure tone audiometer
-
Ministry of Health, MalaysiaCompleted
-
Jessa HospitalCompleted
-
Assiut UniversityNot yet recruiting
-
University of NottinghamNational Institute for Health Research, United Kingdom; International Stem...SuspendedCancer | Hearing Loss, Sensorineural | Tinnitus, Subjective | Chemotherapeutic ToxicityUnited Kingdom
-
Assiut UniversityNot yet recruiting
-
University of California, San FranciscoPatient-Centered Outcomes Research InstituteRecruitingHearing Loss | Hearing Loss, Sensorineural | Hearing Loss, Bilateral | Hearing Loss, Conductive | Hearing Loss, Noise-Induced | Hearing Loss, Unilateral | Hearing Loss, Mixed | Hearing Disorders in ChildrenUnited States
-
Ultrahaptics LtdAvon Partnership NHSCompleted
-
Hospices Civils de LyonWithdrawnCochlear Prosthesis ImplantationFrance